Home infusion therapy market to grow to $71.82b by 2032

It is driven by the aging population and a rise in chronic diseases. 

The home infusion therapy market is set to grow from $35.98b in 2023 to $71.82b by 2032, with a compound annual growth rate (CAGR) of 8.36%, according to a report by SNS Insider.

The growth is driven by increasing demand for home healthcare solutions due to an aging population and a rise in chronic diseases. 

The World Health Organization (WHO) predicts that by 2030, one in six people will be over 60, creating a need for more accessible healthcare services.

Chronic conditions such as diabetes and heart disease require ongoing treatment, which is often better managed at home, the report noted.

“As healthcare providers and systems adapt to these trends, home infusion therapy has become a vital component of the continuum of care, enabling patients to receive necessary treatments while maintaining their independence,” the report said.